VC Firm Arch Venture Inches Closer to $550 Million+ Biotech Fund

Published: Nov 22, 2016

Arch Venture Partners is well along the way to raising a new $550 million-plus fund.

The VC group has posted new forms with the SEC stating that the partners have raised more than $408 million for Arch Venture Fund IX. But it’s unlikely to stop at $550 million. These days, biotech start-up groups like Arch have made it a point of pride to come in over target on the cash. And these partners like to make a splash.

Back to news